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Barcelona, Spain, 3 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain
Abstract
The function of CERKL (CERamide Kinase Like), a causative gene of retinitis pigmentosa and cone-rod dystrophy, still awaits
characterization. To approach its cellular role we have investigated the subcellular localization and interaction partners of
the full length CERKL isoform, CERKLa of 532 amino acids, in different cell lines, including a photoreceptor-derived cell line.
We demonstrate that CERKLa is a main component of compact and untranslated mRNPs and that associates with other RNP
complexes such as stress granules, P-bodies and polysomes. CERKLa is a protein that binds through its N-terminus to
mRNAs and interacts with other mRNA-binding proteins like eIF3B, PABP, HSP70 and RPS3. Except for eIF3B, these
interactions depend on the integrity of mRNAs but not of ribosomes. Interestingly, the C125W CERKLa pathological mutant
does not interact with eIF3B and is absent from these complexes. Compact mRNPs containing CERKLa also associate with
microtubules and are found in neurites of neural differentiated cells. These localizations had not been reported previously
for any member of the retinal disorders gene family and should be considered when investigating the pathogenic
mechanisms and therapeutical approaches in these diseases.
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Introduction
Retinitis pigmentosa (RP) is the most common form of retinal
dystrophies (prevalence of 1:4,000) and is characterized by night
blindness and progressive loss of vision due to photoreceptor
degeneration [1]. RP is a hereditary disorder with extremely high
genetic heterogeneity and to date more than fifty causative genes
have been identified. Among them, CERKL (CERamide Kinase
Like) was first identified in a RP Spanish family [2] and later was
shown to promote cone-rod dystrophy (CRD), a retinal disorder
associated with a more severe phenotype [3]. CERKL encodes a
protein particularly abundant in cones and also present in rods
and at the inner nuclear layer and ganglion cell layer [4,5].
CERKL function, in spite of many studies, is still unknown. Of the
many isoforms reported in human and mouse retina [6], only
CERKLa (hereafter called simply CERKL), the full length protein
that encompasses all thirteen exonic regions and comprises 532
amino acids, is conserved in vertebrates [7].
CERKL belongs to the ceramide kinase (CERK) protein family,
whose members share, in addition to a Pleckstrin homology (PH)
domain, an evolutionary conserved diacylglycerol kinase domain
presumed to be involved in sphingolipid metabolism [8]. Although
the physiological function of this domain in CERKL has been
deeply investigated in vivo and in vitro by different groups
[8,9,10,11], no evidences have been gathered for such a role in
this protein [12]. Also, two nuclear localization signals and two
nuclear export signals have been proposed to regulate a nucleus/
cytoplasm traffic of CERKL [8,9,13], a process that needs to be
accommodated in the function of this protein.
To gain further insights into the cellular role of CERKL we
have investigated its subcellular localization and its interaction
partners in different cell lines, including the photoreceptor-derived
cell line 661W. CERKL was found to colocalize, in a nuclear
import/export-dependent manner, with stress granules (SGs),
which are aggregates that appear when the cells are under stress,
composed of specific proteins (PABP, poly(A) binding protein, and
several initiation factors such as eIF4E, eukaryotic translation
initiation factor 4E, among others), small but not large ribosomal
subunits and polyadenylated mRNAs [14]. CERKL was associ-
ated also with P-bodies (PBs), which are involved in mRNA
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turnover [15], to polysomes and mainly to compact untranslated
messenger ribonucleoprotein particles (mRNPs). CERKL was
found to directly interact through its N-terminal region with
mRNA and also to bind to some proteins of the translation
machinery. In addition, these compact mRNPs also bind to
microtubules and are found in neural differentiated cells. Although
there are other RP-causing genes that encode spliceosome
components or splicing factors, CERKL becomes the first gene
that encodes a protein that binds to mature mRNAs in the
cytoplasm.
Results
CERKL localizes to SGs and P-bodies
Upon transient transfection, CERKL was found in COS-7 cells
both in the cytoplasm and in the nucleus. In the cytoplasm,
although the major part of CERKL was uniformly distributed, it
was also found in the form of aggregates (see Fig. 1A, HA panels).
Therefore, we tried to identify these aggregates using a battery of
organelle markers. These aggregates containing CERKL were
partially found around the nuclear envelope and endoplasmic
reticulum and they were absent from the Golgi complex (cis and
trans Golgi), mitochondria, early, late and recycling endosomes,
clathrin-coated vesicles, lysosomes and autophagosomes (Fig. S1).
Also, these structures neither corresponded to lipid droplets, as
there was no colocalization of CERKL with BODIPY 493 or with
a well established lipid droplet protein (adipose differentiation-
related protein, ADFP), nor to aggregates of misfolded proteins, as
there was no colocalization of CERKL with p62 or with
polyubiquitinated proteins (data not shown). However, CERKL
clearly colocalized with markers of SGs such as poly(A) tails,
PABP, eIF4E, RPS3 (ribosomal protein S3) and G3BP1 (Ras
GTPase-activating protein-binding protein 1) (Fig. 1A and data
not shown).
Although the granules containing CERKL were already
observed in transiently transfected COS-7 cells, their number
increased about 1.5 times under stronger stress conditions such as
exposure to 500 mM sodium arsenite (SA)(Fig. 1B and Fig. S2
upper panel, 14.863.5 vs 9.763.2 per cell, n = 100). Under heat-
shock (as shown for HeLa cells in Fig. S4B) colocalization of
CERKL with SGs was also evident and coupled to a higher
number of CERKL-containing SGs, respectively) (Fig. 1B). This
localization was specific for CERKL, since overexpressed GFP did
not colocalize under any condition with SGs (Fig. S3). In addition,
the localization of CERKL to SGs could be also extended to other
cell types, such as human HeLa cells (Fig. S4) and, of more
relevance since it is in the photoreceptors where CERKL mutations
exert their pathological effects [1], the mouse photoreceptor
derived cell line 661W (Fig. 1C).
In the presence of cycloheximide, an inhibitor of protein
synthesis that causes ribosome stalling, SGs are not further formed
and become disassembled [14]. Therefore, the localization of
CERKL to SGs was lost when this inhibitor was added to both
untreated (Fig. 1D) and SA-treated (Fig. S2) transiently transfected
COS-7 cells and under these conditions the protein was mainly
found diffuse in the cytosol. Similar results were obtained with
HeLa cells exposed to heat-shock (Fig. S4B, two lower panels).
These changes were not due to variations in CERKL, as the total
level of overexpressed CERKL under heat-shock stress was
minimally affected by the cycloheximide treatment (Fig. S4C).
SGs are in dynamic equilibrium with PBs, which are
cytoplasmic organelles involved in mRNA degradation [15].
Figure 1E shows an example of the colocalization of CERKL
with EDC4, a marker of PBs, in transiently transfected COS-7
cells after stress induction with SA. The same colocalization was
also observed in other cells (data not shown).
In summary, the results above show that CERKL, in addition to
be found in the nuclei, has two major patterns of localization in the
cytoplasm, diffuse in the cytosol and aggregated in SGs and PBs, a
localization that resembles that of proteins involved in mRNA
metabolism [16].
CERKL targeting to SGs requires its nuclear import/export
and mRNA transcription
Two nuclear localization signals and two nuclear export signals
have been proposed to regulate CERKL trafficking between the
cytoplasm and the nucleus [8,9,13]. The nuclear export of
CERKL is mediated by binding of the nuclear export signal to
CRM1, as evidenced by the accumulation of CERKL in the
nucleus after treatment with leptomycin B (Fig. 2A and data not
shown). In addition, this treatment confirmed that the localization
of CERKL to SGs requires the export of the protein from the
nucleus. Moreover, when the transcription of DNA was inhibited
with actinomycin D, the CERKL aggregates disappeared and
CERKL accumulated in the nuclei. The same result was obtained
when RNA polymerase II was inhibited with a-amanitin (Fig. 2A),
indicating that export of CERKL and its localization to SGs
depends not only on the export of the protein from the nucleus but
also on an active mRNA transcription.
We observed that a point mutant (C125W) within the PH
domain of CERKL, which occurs in patients of CRD, was unable
to enter the nucleus and remained in the cytoplasm (HA panels in
Fig. 2B). Therefore, we took advantage of this mutant to confirm
the requirement of the shuttling of CERKL between nucleus and
cytoplasm for its localization to SGs. As shown in Figure 2B, the
CERKL-C125W mutant did not show any association to SGs
even after treating the cells with SA.
Therefore, all these results support a dynamic CERKL cycle of
nuclear import/export, which depends on mRNA transcription
and that is necessary for CERKL targeting to SGs. This cycle is
absent in a pathogenic mutant (C125W) of CERKL.
In the absence of stress, most CERKL associates with
polysomes and compact and untranslated mRNP
particles
As mentioned before, SGs are in dynamic equilibrium with
polysomes. Since CERKL colocalized with SGs but it was mainly
found with a uniform distribution in the cytosol, we explored the
possibility that this protein was also present in polysomes. In the
absence of stress, HeLa cells that stably express CERKL-HA did
not form SGs (Fig. S4A and B), in contrast to transiently
transfected cells. Therefore, we isolated polysomes from these
cells in a discontinuous sucrose gradient and analyzed the different
fractions by Western blot. Figure 3A–C (left panels) shows that
CERKL (amino acids 1–532, CERKL WT) in the cytosol localizes
in the pellet (P) of polysomes (detected with antibodies that
recognize proteins from the small or the large ribosomal subunits,
RPS6 or RPL26, respectively). In contrast, a CERKL truncated
protein (amino acids 1–256, CERKL 1–256) that does not shuttle
between the nucleus and the cytoplasm [2] did not associate with
the polysomal pellet (Fig. 3A, right panels). In addition to the
pellet, CERKL WT was also found, and to a higher extent, in the
fractions above it (Fig. 3A, upper left panel).
As expected, the colocalization of CERKL with polysomes was
lost after treatment of the lysates with 15 mM EDTA (Fig. 3B), but
surprisingly not after a treatment with ribonuclease A (RNase A,
Fig. 3C). Moreover, in the latter condition a shift of CERKL from
CERKL Is an mRNA Binding Protein
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the lighter to the heavier fractions of the gradient was observed
(see Fig. 3C, CERKL WT + RNase A). Therefore, we next treated
separately with RNase A the polysomal pellet (P in Fig. 3A–C) and
two of the fractions above containing most of the CERKL protein
(fractions 2 and 3 in Fig. 3A–C) and subjected them to a second
centrifugation in a continuous sucrose gradient. The association of
CERKL to the original pellet (polysomes) was now sensitive, as
expected, to the RNase A treatment and CERKL moved to the
lighter sucrose fractions (Fig. 3D). However, CERKL in the two
original soluble fractions 2 and 3 accumulated under our standard
conditions (25 mM NaCl) in the heavier fractions and in the pellet
of the continuous sucrose gradient (Fig. 3E). In these fractions,
RNase A and RNA also accumulated (Fig. 3E, see Western blot
below in the right panel and the line graphs below), because
RNase A forms complexes [17] that can trap the mRNAs and
their associated proteins. This explains the presence of CERKL in
the heavier fractions and in the pellet from the lysates treated with
RNase A (Fig. 3C).
We reasoned, therefore, that the soluble fractions contain
CERKL and mRNA in a quite folded conformation that results in
a compact and RNase A-insensitive structure. Accordingly, when
RNase A was added to these same fractions in the presence of a
high salt concentration (450 mM), CERKL, together with RNase
A and RNA, were displaced to the lighter fractions of the
continuous density sucrose gradient (Fig. 3F, compare with
Fig. 3E). This result confirms the compact nature of these
particles, which only become relaxed and RNase A-sensitive in the
presence of a high salt concentration. In addition, treatment of
these fractions with 30 mM EDTA or with 1 mM puromycin did
not change the CERKL distribution in the gradient at any salt
Figure 1. CERKL localizes to SGs and P-bodies. A and B) Colocalization of CERKL (HA) with three markers of SGs (PABP and eIF4E, detected with
specific antibodies described in the Materials and Methods section), and the mRNAs poly(A) tail, detected with oligo(dT) FISH (upper, middle and
lower panels, respectively) in COS-7 cells overexpressing CERKL-HA, either untreated (A) or incubated with 500 mM sodium arsenite for 30 min (B). C)
The localizations of PABP and CERKL (HA) in transfected 661W mouse photoreceptor derived cells were compared by immunofluorescence. Images at
higher magnification of the rectangles in the upper row are shown below. D) COS-7 cells transfected with CERKL-HA were untreated (MOCK) or
treated for 30 min with 100 mg/mL cycloheximide (CHX) and the localizations by immunofluorescence of PABP and CERKL (HA) were compared. E)
COS-7 cells were transfected with CERKL-HA and treated with sodium arsenite as in B. The localizations by immunofluorescence of CERKL (HA) and
the P-body marker EDC4 were compared. Images at higher magnification of the rectangles in the upper row are shown below. Arrowheads indicate
various colocalizations. All bars: 10 mm.
doi:10.1371/journal.pone.0087898.g001
CERKL Is an mRNA Binding Protein
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concentration (Fig. 3G). This indicates the absence of whole
ribosomes and, therefore, that translation does not take place in
these complexes.
CERKL is an mRNA binding protein that interacts with
components of the translation machinery
Until now, we have shown that CERKL is present in SGs,
polysomes, PB and other mRNP compact particles. All these
structures share mRNAs and proteins involved in mRNA
metabolism, most of which also shift from the nucleus to the
cytoplasm [18,19]. To study if CERKL interacted with some of
them, we performed immunoprecipitation experiments followed
by liquid chromatography-tandem mass spectrometry. Table S1
shows a list of the twenty-seven identified proteins that interacted
with CERKL. The majority (eighteen) corresponded to proteins
involved in translation and protein folding, including PABP,
HSP70 (known to assist in the folding of the nascent polypeptides),
RPS3 and the translation initiation factor eIF3B. All these
proteins, except eIF3B, also interacted with the Flag-tagged
CERKL-C125W mutant (Fig. 4A). These interactions were
subsequently corroborated by co-immunoprecipitation experi-
ments followed by Western blots (Fig. 4B). Again, the protein
eIF3B was shown to co-immunoprecipitate with CERKL-WT but
not with the CERKL-C125W mutant.
To analyze the possibility that CERKL also binds to mRNA,
RNA Electrophoretic Mobility Shift Assays (EMSA) were carried
out using purified His-Maltose binding protein (MBP)-CERKL
fusion proteins and biotinylated mRNAs isolated from human
retina (Fig. 4C) or from COS-7 cells (Fig. S5). Some specific shifted
bands were observed, indicating the formation of complexes
between CERKL and some mRNAs. These complexes appeared
at protein concentrations as low as 0.4 and 0.8 mM (with mRNAs
from human retina and COS-7 cells, respectively) and contained
CERKL as assessed by Western blot (data not shown). When
bovine serum albumin (BSA) or MBP replaced CERKL, no shifted
bands were produced. In addition, an excess of the non-
biotinylated probe reduced the intensity of the shifted bands.
Finally, the CERKL-mRNA binding could not be eliminated in a
competition assay with tRNAs from Saccharomyces cerevisiae (data not
shown). All these controls support the specificity of the CERKL-
mRNA interaction.
To determine more accurately the CERKL domains responsi-
ble for the interaction with mRNA, two shorter peptides covering
the full size protein were analyzed by EMSA, one comprising
amino acids 1 to 256 and the other containing amino acids 252 to
532. Only the first peptide interacted with the mRNAs (Fig. 4D),
indicating that the initial part of the protein is involved in this
interaction. In addition, when possible sites of interaction with
CERKL in the mRNAs were analyzed, we found that CERKL
interacted with the 59cap structure of mRNAs, since CERKL-Flag
but not GFP-Flag was bound to 7-methylguanosine in an affinity
assay with m7-GTP-Sepharose 4B beads (Fig. 4E). Moreover,
since the C125W mutant also interacted with the 59cap structure
(data not shown), the cause of exclusion of C125W from SGs
should not be due to a restricted binding but rather to a nucleus/
cytoplasm shuttling defect.
In the compact mRNPs most of the interactions of CERKL
with the components of the translation machinery occur
in an mRNA-dependent manner
Concerning the four proteins of the translation machinery that
were identified to be associated with CERKL (see Fig. 4A and B
and Table S1), this association can occur by direct protein-protein
interaction but also in an mRNA-dependent manner. Treatment
Figure 2. Formation of SGs by overexpression of CERKL requires the nuclear import/export of the protein. A) COS-7 cells
overexpressing CERKL-HA were mock-treated (upper row) or treated for 2 h with 40 nM leptomycin B (LeptB), 1 mg/mL actinomycin D (ActD) or
100 mg/mL alpha-amanitin (a-Aman). Then, the localizations of CERKL (HA) and PABP (marker of SGs) were investigated by immunofluorescence. B)
COS-7 cells overexpressing the CERKL-C125W mutant were mock-treated or treated with 500 mM SA for 30 min and the localizations of the mutant
CERKL (CERKL C125W-HA) and PABP (upper panels) or eIF4E (lower panels) were investigated by immunofluorescence. Images at higher
magnification of the rectangles are shown on the right. All bars: 10 mm.
doi:10.1371/journal.pone.0087898.g002
CERKL Is an mRNA Binding Protein
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of the lysates with RNase A did not affect these interactions
(Fig. 5A). However, the results from Figure 3E and F showed that
CERKL was associated with quite compact mRNPs, which only
became sensitive to RNase A when they acquired a more relaxed
conformation in the presence of high salt concentrations.
Therefore, we carried out the immunoprecipitation experiments
of Flag-tagged CERKL after treating the cell lysates with RNase A
at different salt concentrations (150, 450 and 600 mM NaCl)
before immunoprecipitation. As shown in Figure 5A, in the
presence of high salt concentrations RNase A affected the
interaction of CERKL with PABP, HSP70 and RPS3. These
effects were not observed with the CERKL-C125W mutant
(Fig. 5B). In contrast to PABP, HSP70 and RPS3, the interaction
of CERKL-WT with eIF3B was not lost under high salt conditions
(Fig. 5A, upper gel). Therefore, except for eIF3B, in the compact
mRNP particles the interaction of CERKL with the three
remaining proteins here investigated occurred in an mRNA-
dependent manner.
Compact CERKL-mRNPs interact with microtubules
Alpha- and beta-tubulin were among the proteins identified in
the immunoprecipitation experiments with CERKL (Fig. 4A and
table S1). This association was further corroborated by immuno-
fluorescence (Fig. 6A). In addition, when the cells were fixed with
2% instead of 4% paraformaldehyde, a filamentous appearance of
CERKL was noticed that was disrupted by a colchicine treatment,
indicating that this distribution was due to its interaction with
microtubules (Fig. 6A, lower panels). CERKL also co-localized
with other structures related to microtubules, such as the mitotic
spindle or the centrosome (Fig. 6B). The interaction of CERKL
with a- and b-tubulin was also confirmed by co-immunoprecip-
itation (Fig. 6C). To determine whether the interaction of CERKL
with microtubules was necessary for the formation of the CERKL
complex with the proteins of the translation machinery, we
performed co-immunoprecipitation experiments in the presence or
absence of colchicine. As expected, the interaction of CERKL
with a- and b-tubulin was lost after colchicine treatment,
Figure 3. CERKL localizes to polysomes and compact mRNPs. A) HeLa cells stably expressing CERKL WT-HA or an N-terminal fragment of the
protein (CERKL 1-256-HA), generated as described in the Materials and Methods section, were lysed and polysomes were isolated by centrifugation in
a 0.5-1.3-1.7-2.1 M discontinuous sucrose gradient. Seven 1 ml fractions (1–7) and the pellet (P) were analyzed by immunoblot using antibodies that
recognize HA, the ribosomal protein RPS6. Actin was used as control. B and C) Similar experiments were carried out incubating the cell lysates with
EDTA (15 mM) (B) or RNase A (100 mg/mL) (C) before centrifugation. Antibodies that recognize HA and the ribosomal proteins RPS6 and RPL26 were
used. D–F) The pellet (D) and fractions 2 and 3 of the gradient (E and F) were treated with 25 mM (D and E) or 450 mM (F) NaCl, with or without
RNase A (100 mg/mL) and subsequently centrifuged in a continuous sucrose density gradient (0.3–1.5 M) as described in Materials and Methods. The
new fractions (1–11, in D and 1–10, in E and F) and the pellet (P) were immunoblotted with HA and RPS6 (D) or RNase A (E and F) antibodies. Below
the Western blots, the concentration of RNA quantified at 260 nm is shown. G) The same experiment as in E and F, with fractions 2 and 3 treated
with 30 mM EDTA or 1 mM puromycin at 25 mM and 450 mM NaCl before the continuous sucrose gradient. Ten fractions and the pellet were
analyzed by immunoblot using antibodies that recognize HA.
doi:10.1371/journal.pone.0087898.g003
CERKL Is an mRNA Binding Protein
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confirming that it was bound to microtubules (Fig. 6C). However,
the interaction of CERKL with the different proteins of the
translation machinery was not affected by the colchicine treatment
(Fig. 6C). According to these data, we can conclude that the
interaction of CERKL with the proteins of the translation
machinery does not require the integrity of the microtubules
and, therefore, that the complex binds to them after it has been
formed.
When cells are fixed with 2% paraformaldehyde, CERKL can
be also observed in the form of particles of 100–250 nm diameter
(Fig. 6D). To verify that these complexes actually bind to
microtubules, we immunoprecipitated CERKL from a purified
cytoskeletal fraction (Fig. S6) and confirmed the interaction of
CERKL with eIF3B, PABP, HSP70 and RPS3 (Fig. 7). In this
fraction, the interaction of CERKL with these proteins was not
sensitive to EDTA (Fig. 7A) and, except for eIF3B, it was only
sensitive to RNase A at a high salt concentration (Fig. 7B). These
results indicate that CERKL and the other proteins form compact
mRNP complexes independently of 80S ribosomes and, therefore,
that the mRNAs in these complexes are untranslated.
CERKL colocalizes with microtubules and components of
the translation machinery in neurites of differentiated
human neuroblastoma cells
We have observed that CERKL associates with translationally
inactive compact mRNPs that bind to microtubules. We next
analyzed if this also happens in human differentiated SH-SY5Y
Figure 4. CERKL interacts with components of the translation machinery and with mRNAs. A) HEK-293T cells overexpressing Flag-tagged
GFP, CERKL- WT or CERKL-C125W were lysed and Flag was immunoprecipitated as described in Materials and Methods, analyzed by SDS-PAGE in 8%
(left panel) and 20% (right panel) polyacrylamide gels and silver-stained. Proteins were characterized by mass spectrometry (see Materials and
Methods). The positions of the proteins are indicated by arrows, from up to down as follows: eIF3B (1), CERKL (2), alpha-tubulin (3), ß-tubulin (4)
(8%polyacrylamide gel), PABP (5), HSP70 (6), CERKL (7) and RPS3 (8) (20% polyacrylamide gel, WT lane) and GFP (9) (20% polyacrylamide gel, GFP
lane). B) Flag immunoprecipitations (FLAG IP) of protein homogenates from HEK 293T cells transfected with CERKL-Flag (WT), CERKL-C125W-Flag
(CW) or, as a control, GFP-Flag (GFP). The position of CERKL and GFP, detected with anti-Flag, is shown. Specific antibodies were used to detect eIF3B,
PABP, HSP70 and RPS3. C) EMSA of CERKL protein incubated at the indicated concentrations with biotinylated mRNAs from human retina. BSA
(CONTROL) and His-MBP (0) were used as negative controls. Addition of an excess of non-biotinylated probes reduced the intensity of the shifted
bands (COMPETITION). Arrowheads indicate the position of the shifted bands. D) Two CERKL proteins moieties, Nter (amino acids 1–256) and Cter
(amino acids 252–532) and the two negative controls from C were analyzed by EMSA using biotinylated mRNAs from COS-7 cells. Arrowhead
indicates the position of the shifted band. E) Flag-tagged CERKL-WT or GFP proteins transiently expressed in HEK 293T cells were purified by
immunoprecipitation, eluted with Flag peptide and then incubated with m7-GTP bound to Sepharose 4B beads (M7-GTP). Proteins bound to these
beads were analyzed by Western blot with anti-Flag. As control, unconjugated Sepharose 4B beads (Seph) were used. Only CERKL-WT-Flag, but not
GFP-Flag, binds to m7-GTP-Sepharose.
doi:10.1371/journal.pone.0087898.g004
CERKL Is an mRNA Binding Protein
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neuroblastoma cells because these cells present more structural
similarities with retinal ganglionar cells and photoreceptors, which
are the main targets of the CERKL defects and are also the cells
where this protein is more abundant. In the neurites of these cells,
CERKL colocalized with acetyl-alpha-tubulin, thus indicating
again its association with microtubules (Fig. 8A). In addition,
CERKL also presented a particulated distribution that colocalized
with eIF3B, PABP and RPS3 (Fig. 8B–D). The fact that these
particles also contained RNA (propidium iodide staining in Fig. 8E,
left panels) indicated that the CERKL-containing mRNPs are also
found in neurites in differentiated cells. Noticeably, the CERKL-
C125W mutant (Fig. 8E, right panels) neither presented this
particulated distribution nor colocalized with RNA, confirming its
inability to form mRNPs.
Discussion
Within the last two and a half decades, technological advances
have led to a progress in gene identification of retinal diseases.
However, the function of a high number of the over hundred
retinal diseases and fifty RP genes known remains to be
characterized. Functional studies have been hampered mainly by
the lack of suitable animal and cellular models, the intracellular
complexity and specific metabolic demands of the retinal cells and
the extensive genetic, allelic and clinical heterogeneity associated
with the majority of retinal degenerative disorders. Within this
context, CERKL, an autosomal recessive RP and CRD -causing
gene, stands among the genes whose function awaits character-
ization. In fact, repeated attempts by several groups to assign a
ceramide kinase function to CERKL have proved fruitless
[8,9,10,12].
Therefore and to gain some insight into CERKL function we
investigated here in detail the subcellular localization and the
interaction partners of the CERKL full length protein isoform
(CERKLa). The protein was localized both in the nucleus and in
the cytoplasm of various cell types, in agreement with other studies
[8,9,10,20]. Although the CERKL distribution appeared to be
mainly homogeneous, some aggregates became apparent in the
Figure 5. In the compact mRNPs, CERKL interacts with PABP, HSP70 and RPS3 in an mRNA-dependent manner. A and B) HEK-293T
cells were transfected with CERKL-WT (A) or with CERKL-C125W mutant (B). After 48 h, cells were treated with 100 mg/ml cycloheximide and lysates
were treated or not with RNase A (100 mg/mL) in the presence of three different concentrations of NaCl (150, 450 and 600 mM, as indicated). Then,
the lysates were immunoprecipitated with anti-Flag M2 affinity beads. The co-immunoprecipitated proteins were analyzed by immunoblot using
antibodies that recognize eIF3B (only in A), PABP, HSP70, RPS3 and Flag (to detect CERKL-WT and its C125W mutant). In the histograms below, the
bands corresponding to the various proteins recovered after the Flag IP, in the presence of RNase A, were quantified with respect to CERKL-WT (A) or
CERKL-C125W (B) in each lane. Values are the mean from 4 different experiments. Stars indicate statistically significant differences from the values in
the presence of 150 mM NaCl (*p,0.05, **p,0.01 and ***p,0.005).
doi:10.1371/journal.pone.0087898.g005
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cytoplasm of transiently transfected cells. A systematic analysis in
cultured cells using different markers of various cell compartments
revealed that CERKL aggregates colocalized with SGs, which are
cytoplasmic complexes of mRNAs and mRNA-binding proteins
such as those that regulate mRNA translation and stability [21].
These granules are induced by stress conditions and provide the
cells with a mechanism to stop protein synthesis and promote a
quick recovery of proteostasis when the stress disappears.
Targeting to SGs under stress conditions would agree with
CERKL protective role from apoptosis induced by oxidative stress
[10]. In addition to SGs, CERKL was also found associated with
P-bodies, which are involved in mRNA degradation and are in
dynamic equilibrium with SGs [22]. Also in support to a CERKL
contribution to stress response and protection of photoreceptors is
the punctuated CERKL labeling noticed after a light stress in the
outer nuclear layer of rat photoreceptors [4].
The CERKL-C125W mutant, which does not enter the
nucleus, is not found in SGs. In fact, the localization of wild type
CERKL to SGs seems to depend on nuclear import/export of the
protein and on mRNA transcription. Therefore, we reasoned that
CERKL has a role in the nucleus before it associates with SGs,
probably related to RNA transport. In fact, CERKL subcellular
localization studies have shown strong accumulation in the
nucleoli [10]. Whether this is related to particular protein isoforms
or depends on the cellular state deserves further study. Actually,
there are other genes mutated in RP that are involved in RNA
metabolism at the nucleus, such as the spliceosome components
PRPF31, PRPF8 and PRPF3, or the RNA splicing factor RP9
[1,23]. Recently, in age-related macular degeneration, SFRS10
Figure 6. CERKL interacts with microtubules. A) COS-7 cells overexpressing CERKL were fixed with 2% paraformaldehyde and the localizations
of CERKL (HA) and ß-tubulin were compared by immunofluorescence. As control, cells were treated with 1 mg/ml colchicine (COL) for 2 h to disrupt
microtubules. Bar: 10 mm. B) CERKL colocalizes with microtubule-related structures. COS-7 transfected cells were fixed with 2% paraformaldehyde
and the localization of CERKL (HA) was compared by immunofluorescence with that of acetyl-a-tubulin (upper panels) and the centrosomal protein
pericentrin (lower panels, arrowhead) using specific antibodies. Images at higher magnification of the rectangles in the upper row are shown below.
All bars: 10 mm. C) Immunoblot of alpha and ß-tubulin, eIF3B, PABP, HSP70 and RPS3 proteins co-immunoprecipitating with CERKL-Flag or GFP-Flag
in the presence (+) or not (2) of 1 mg/ml colchicine (COL), as indicated. Bottom, CERKL and GFP in the various lanes using anti-Flag. D) COS-7 cells
transfected with CERKL-HA were fixed with 2% paraformaldehyde and CERKL (HA) was localized by immunofluorescence. Images at higher
magnification of the rectangles are shown on the right. Arrowheads indicate the particles containing CERKL. Bars: 10 mm (original image) and 2 mm
(zoom).
doi:10.1371/journal.pone.0087898.g006
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has been reported to regulate alternative splicing of stress response
genes under hypoxic conditions [24].
In the cytosol, apart from the localization of CERKL in
aggregates, the protein was mostly found diffusely distributed. This
was particularly evident in HeLa cells stably expressing this
protein. Since SGs are in dynamic equilibrium with polysomes, we
analyzed whether this diffuse localization of CERKL could
correspond to its binding to polysomes. Using sucrose gradients,
CERKL localized to the polysomal pellet and to a greater extent
in the soluble fractions that contained postpolysomal mRNPs.
Contrary to polysomes, the association of CERKL to these
fractions was not sensitive to EDTA or puromycin and was only
sensitive to RNase A at high salt concentrations. Therefore, it
appears that CERKL in these fractions is associated with quite
compact mRNPs.
The association of CERKL to mRNPs can occur by protein-
RNA and protein-protein interactions. Our data show that
CERKL directly interacts with mRNA through its N-terminal
region and that this link involves the 59cap structure of mRNA.
Since in the proteomic analysis (table S1) we did not observe any
interaction between CERKL and the two mammalian proteins
known to bind directly to the 59cap structure, elF4E and nCBC
[25], and since eIF4E was not detected in immunoprecipitation
assays (data not shown), the CERKL-mRNA association is
probably direct. However, we cannot exclude an interaction with
a yet unidentified component of the 59cap structure. In addition,
CERKL was found to bind to proteins of the translation
machinery, such as PABP, eIF3B, HSP70 and the ribosomal
protein RPS3, all of which are found in SGs and in other mRNPs,
such as neuronal and transport granules [21,26,27,28,29]. Except
for eIF3B, the interaction of CERKL with these proteins was
mRNA-dependent, mostly forming compact RNPs. Interestingly,
the CERKL-C125W mutant did not interact with eIF3B and its
binding to the other proteins was not sensitive to RNase A even at
high salt concentrations, indicating the absence of RNA in these
complexes. This together with the restricted nuclear/cytoplasmic
shutling ability shown for this mutant could explain why it is not
found in Sgs.
Figure 7. The compact CERKL-mRNP complexes interact with microtubules. HEK-293T cells were transfected with CERKL-WT and after 48 h
a cytoskeletal fraction was isolated from the cells as described in Materials and Methods. Fractions were treated with 15 mM EDTA (A) or 100 mg/ml
RNase A (B) in the presence of 150, 450 and 600 mM NaCl, as shown in the figure, and then subjected to immunoprecipitation with anti-Flag M2
affinity beads. The co-immunoprecipitated proteins were analyzed by immunoblot using antibodies that recognize eIF3B, PABP, HSP70, RPS3 and
Flag (for CERKL). In the histograms below, the bands corresponding to the various proteins recovered after the Flag IP, in the presence of RNase A,
were quantified with respect to CERKL-WT (A) or to CERKL-C125W (B) in each lane. Values are the mean from 4 different experiments. Stars indicate
statistically significant differences from the values in the presence of 150 mM NaCl (*p,0.05, **p,0.01 and ***p,0.005).
doi:10.1371/journal.pone.0087898.g007
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CERKL-containing compact mRNPs were found associated
with microtubules and in the cytoskeletal fraction. In fact, CERKL
contains a PH domain that is also present in proteins that bind to
microtubules [30]. This association could be found here in distal
compartments of differentiated neural cells. These results suggest a
role of this protein in the transport of the mRNAs present in these
structures, although this needs to be further investigated. In this
regard, it is known that a compact packaging of mRNAs into
mRNPs is essential to protect the mRNAs and to guarantee their
survival until translation occurs [31]. The assembly of these
mRNPs starts while the mRNA is still being transcribed. This
explains the requirements of an active transcription, the nuclear
import/export cycle of CERKL and why the CERKL C125W
mutant is unable to form these complexes. Although we have
highlighted a new cellular role of CERKL and shown that a
pathological mutant lacks these features, further studies are needed
to substantiate the in vivo role of CERKL variants in the retina,
focusing on the relationship between the protein isoforms, their
intracellular localization and the disease phenotype.
In summary, our data unveil a novel cellular localization
associated with hereditary retinal disorders. CERKLa is a new
component of a group of compact mRNPs containing proteins of
the translation machinery and untranslated mRNAs. If these
mRNPs include mRNAs relevant for the normal function of
retinal cells, currently being studied, this would provide the basis
to understand the physiological disturbances caused by the
different mutations in this protein and the mechanism of retinal
degeneration in health and disease, and unveil new pathways to
identify molecular targets for therapy.
Materials and Methods
Expression plasmids and transfections
For transfection assays, the CERKL cDNA transcript
variant 1 (NM_201548.4) was cloned into pEGFP-C2 (Addgene)
Figure 8. CERKL localization in differentiated SH-SY5Y neural cells. A) SH-SY5Y cells were transfected with CERKL-HA and after 48 h cells
were differentiated with 10 mM retinoic acid. The distribution of CERKL and acetyl-a-tubulin were compared after 36 h by immunofluorescence.
Images at higher magnification of the rectangles in the upper row are shown below. B–D) SH-SY5Y were transfected and differentiated as in A.
Images show colocalization by immunofluorescence of CERKL (HA) with eIF3B (B), PABP (C) and RPS3 (D) in differentiated SH-SY5Y cells. Images at
higher magnification of the rectangles in the upper row are shown below. E) Colocalization of CERKL-WT and CERKL-C125W (HA) with RNA
(propidium iodide staining, PI) in differentiated SH-SY5Y cells. Arrowheads show colocalization in particulated structures. The scatter diagrams below
show colocalization dots. Bars: 10 mm (original images) and 5 mm (zoom).
doi:10.1371/journal.pone.0087898.g008
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(CERKL-GFP) and into modified versions of pcDNA (Clontech
Laboratories, Inc.), which add a C-terminal hemagglutinin
(CERKL-HA) or a Flag (CERKL-Flag) tag. The mutant encoding
amino acids 1 to 256 tagged with HA was cloned into pcDNA
(CERKL 1–256). All constructs were generated using standard
recombinant DNA techniques. A plasmid expressing Flag-GFP
was kindly provided by Dr. A.T. Ting (Mount Sinai School of
Medicine, NY, USA). A CERKL-C125W point mutant was
generated using the QuikChange XL site-directed mutagenesis kit
(Stratagene/Agilent Technologies), according to the manufactur-
er’s instructions. To produce recombinant MBP-CERKL fusion
proteins in E. coli, the cDNA encoding the full length CERKL
protein or its amino acids 1–256 and 252–532 were inserted into
the pDEST-His-MBP vector (Addgene) using the Gateway
recombination cloning kit (Invitrogen Life Technologies). All
constructs were confirmed by sequence analysis.
Cell culture and stress treatments
COS-7, HEK-293T, HeLa (ECACC, Salisbury, UK), 661W
[32] and SH-SY5Y (ATCC, LGC Standards, Barcelona, Spain)
cells were grown in DMEM with 4 mM L-glutamine supplement-
ed with 10% fetal bovine serum, 100 U/mL penicillin and
100 mg/mL streptomycin (Invitrogen Life Technologies). As for
661W cells, the medium was supplemented with 0.002%
2-mercaptoethanol. HeLa cells stably expressing CERKL were
generated by transfection with pcDNA-CERKL-HA and positive
clones were selected with G418 (Invivo Gen). The human
neuroblastoma cell line SH-SY5Y was transfected with CERKL-
HA and after 48 h the cells were differentiated by incubating them
in DMEM supplemented with 0.5% fetal bovine serum and
10 mM retinoic acid (Sigma-Aldrich). Experiments were per-
formed after thirty-six additional hours. For transfection, we used
FuGene HD (Roche Diagnostics) and Metafectene Pro (Biontex)
following the manufacturer’s instructions. All cells were main-
tained in a sterile humidified environment at 37uC in a 5% CO2
atmosphere. Where indicated, cells were treated, after 36 or 48 h
of transfection, with 40 nM leptomycin B, 1 mg/mL actinomycin
D, 100 mg/mL cycloheximide or 100 mg/mL alpha-amanitin (all
from Sigma-Aldrich) for the indicated times. For induction of
stress, cells were incubated for 30 min either at 44uC (heat shock)
or with 0.5 mM sodium arsenite (Sigma-Aldrich). In some of the
samples, cell stress was induced 15 min before the cycloheximide
treatment.
Immunofluorescence, fluorescence in situ hybridization
and confocal microscopy
Immunolocalization was performed as previously described
[10,33] incubating the cells with anti-HA mouse monoclonal
antibody (1:100, Abcam) and with either of the following
antibodies (all from rabbit): anti-calnexin, anti-GM130 and anti-
TGN48 (1:100, BD Biosciences), anti-EEA1, anti-EDC4, anti-
Rab11a, anti-clathrin, anti-LAMP1, anti-eIF4E, anti-PABP, anti-
G3BP 1, anti-AFDP, anti-EDC4, anti-pericentrin and anti-b-
tubulin (1:100, Abcam), anti-LBPA (1:100, Echelon Biosciences),
anti-LC3 (1:200, Nanotools), anti-p62 and anti-ubiquitinated
proteins (1:200, Enzo Life Sciencies). Upon washing, cells were
incubated, as appropriate, with AlexaFluor 488-conjugated anti-
rabbit or AlexaFluor 546-conjugated anti-mouse secondary
antibodies (1:300, Molecular Probes). For a- and b-tubulin
staining, cells were fixed with 2% paraformaldehyde in PBS. To
disrupt microtubules, cells were incubated for 2 h with 1 mg/ml
colchicine (Sigma-Aldrich). Controls were carried out in the
absence of the primary antibodies. In colocalization experiments,
cross-binding controls using the two secondary antibodies with
each primary antibody were also included. Mitochondria were
labeled by adding reduced MitoTracker Orange (Invitrogen Life
Technologies) to the cell culture medium at a final concentration
of 500 nM for 45 min. Lipid droplets were stained with BODIPY
493 (Invitrogen Life Technologies). Slides were counterstained
with 1:5,000 DAPI nuclear blue dye (Roche Diagnostics) in PBS
for 15 min. Fluorescence in situ hybridization (FISH) with
biotinylated oligo(dT) (Sigma-Aldrich) was carried out as previ-
ously described [34].
All preparations were mounted in Fluoprep medium (BioMér-
ieux) or in FluorSave reagent (Calbiochem-Merck4Biosciences)
and images were obtained with a confocal microscope (SP2; Leica
Microsystems) or with an Apotome-equipped Axio Observer Z1
microscope (Carl Zeiss AG).
Isolation of polysomes
Polysomes were isolated as described elsewhere with some
modifications [35,36]. After 30 min treatment with cycloheximide,
HeLa cells stably transfected with CERKL-HA were collected and
homogenised in 0.25 M sucrose, 25 mM NaCl, 5 mM MgCl2,
50 mM Tris pH 7.4, for 7 min at 200 psi in a N2 cavitation pump
(Parr Instruments Co.), followed by five passages through a 25G-
gauge needle. The homogenates were centrifuged at 10,000 g for
10 min. In separate control experiments, 15 mM EDTA or
100 mg/ml RNase A (Sigma-Aldrich) were added to disrupt
polysomes. The supernatants were applied onto the top of a
discontinuous sucrose gradient (0.5, 1.3, 1.7 and 2.1 M sucrose
plus 5 mM MgCl2 and 1 mM dithiothreitol) and centrifuged at
53,000 rpm for 2 h in a 70.1 Ti rotor (Beckman). Seven fractions
(about 1 ml) were collected, precipitated with 10% trichloroacetic
acid and used, together with the ultracentrifugation pellet, for
protein analysis by Western blot. A second continuous sucrose
gradient (0.3–1.5 M) was employed to further analyze separately
the pellet and a mix of two of the upper fractions of the
discontinuous gradient by centrifugation at 28,000 rpm for 4 h in
an SW40 rotor (Beckman). Ten or eleven fractions and the pellet
were analyzed as above.
Immunoprecipitation
Immunoprecipitation of Flag-tagged proteins was carried out
essentially as previously described [37]. Where indicated, cells
were treated with 100 mg/ml cycloheximide prior to lysis in 1%
Triton X-100, 150 mM NaCl, 20 mM Tris, pH 7.4, containing
0.1 mM leupeptin, 1 mM phenyl methane sulfonyl fluoride,
10 mM pepstatin A, 50 mM NaF, 30 mM Na4P2O7 (lysis buffer).
The resulting extracts were sonicated (output: 9 watts) 3 times (20
seconds each) with a Microson Ultrasonic cell disruptor, incubated
next with albumin conjugated agarose beads and centrifuged at
12,000 g for 15 min. The pre-cleared lysates were then incubated
with M2 Flag beads (Sigma-Aldrich) for 1 h at 4uC and, upon
extensively washing, immunoprecipitated proteins were eluted
with 300 mg/mL Flag peptide (Sigma-Aldrich) for 1 h at 4uC.
Treatments with EDTA (15–30 mM), puromycin (1 mM, Sigma-
Aldrich) or RNase A (100 mg/mL) at the indicated salt concen-
trations were carried out where indicated after pre-clearing the
samples with the agarose beads.
Liquid chromatography-tandem mass spectrometry
CERKL-Flag, CERKL-C125W-Flag and GFP-Flag were im-
munoprecipitated as described above and proteins were separated
in 8% and 20% polyacrylamide gels. All following treatments were
conducted at the CIPF proteomic core facility. After silver
staining, differential bands were excised and digested with
sequencing grade trypsin as described elsewhere [38]. The final
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peptide solution was concentrated and analyzed by mass
spectrometry (Nano ESQqTOF, AB SCIEX, Framingham,
MA). Protein identification was carried out using the ProteinPilot
(AB SCIEX) search engine on the ExPasy protein database. The
accuracy of proteins identification was considered when at least
three peptides were identified with a minimum overall MASCOT
score .50.
RNA electrophoretic mobility shift assays
His-MBP-CERKL fusion proteins were produced in E. coli and
purified with the His SpinTrap kit (GE Healthcare). Messenger
RNA was purified from total RNA from COS-7 cells and from
human retina using the Oligotex mRNA kit (Qiagen) and
biotinylated using the RNA 39 biotinylation kit (Thermo Fisher
Scientific). EMSA was conducted using LightShift Chemilumines-
cent RNA EMSA kit (Thermo Fisher Scientific) according to the
manufacturer’s protocol. BSA was used as a negative control. The
protein-probes complexes were resolved in a 6% polyacrylamide
native gel and transferred to a Hybond-N+ Nylon membrane (GE
Healthcare). Migration of biotin-labeled probes was detected on
an ImageQuantTM LAS 4000 biomolecular imager (GE Health-
care) using streptavidin-horseradish peroxidase conjugates and
chemiluminescent substrates for biotin recognition.
7-methylguanosine affinity assay
Immunoprecipitated CERKL-Flag or GFP-Flag were incubated
overnight at 4uC with m7-GTP-Sepharose or Sepharose-4B beads
(GE Healthcare Life Sciences) in the immunoprecipitation lysis
buffer. Sepharose beads were centrifuged and washed three times
in the same buffer containing 450 mM NaCl. Proteins were eluted
by incubating the beads in SDS-PAGE loading buffer at 70uC for
20 min, separated from the beads using the Pierce Spin Cups with
cellulose acetate filter (Thermo Fisher Scientific) and then
analyzed by Western blot.
Isolation of a cytoskeletal fraction
A cytoskeletal fraction was isolated with the Subcellular Protein
Fractionation Kit (Thermo Scientific) according to the manufac-
turer’s instructions. The cytoskeletal pellet was resuspended in the
immunoprecipitation lysis buffer, sonicated 2 times (output 6
watts, 20 seconds each) with a Microson Ultrasonic cell disruptor
and centrifuged at 12,0006g for 10 h at 4uC. Supernatants were
collected and used for subsequent analysis.
Other procedures
Western blot was carried out essentially as described [39], using
the following primary antibodies: anti-HSP70, anti-eIF3B, anti-
HA, anti-PABP, anti-ribosomal proteins S3, S6 and L26, anti-
RNase A, anti a- and b-tubulin (all from Abcam), anti-Flag and
anti-actin (Sigma-Aldrich), followed by the corresponding horse-
radish peroxidase-conjugated secondary antibodies (all from
Sigma-Aldrich). Protein concentration was determined using the
BCA Protein Assay Kit (Thermo Fisher Scientific) according to the
manufacturer’s instructions. Comparisons among different condi-
tions, after calculating mean and SD values, were by Student’s t
test. Differences were considered significant at *P,0.05, **P,0.01
and ***P,0.005.
Supporting Information
Figure S1 CERKL does not colocalize with various
organelle markers. The localization of CERKL in COS-7
cells overexpressing CERKL-HA was compared to that of: A)
calnexin (endoplasmic reticulum); B and C) GM130 and TGN48
(cis and trans Golgi, respectively); D) Mitotracker (mitochondria);
E, F and G) EEA1, LBPA and Rab11a (early, late and recycling
endosomes, respectively); H) clathrin (clathrin-coated vesicles); I)
LAMP1 (lysosomes), and J) LC3 (autophagosomes). No colocaliza-
tion with any of these organelle markers was found and only a
partial distribution of CERKL around the endoplasmic reticulum
was observed (in A). Bar: 10 mm.
(TIF)
Figure S2 Localization of CERKL to stress granules is
lost in the presence of cycloheximide. COS-7 cells
transfected with CERKL-HA were incubated with 500 mM
sodium arsenite (SA) for 1 h. In the last 30 min of incubation,
100 mg/mL cycloheximide (CHX) was added. The localizations of
CERKL (HA) and PABP were compared by immunofluorescence.
Bar: 10 mm.
(TIF)
Figure S3 GFP does not colocalize with stress granules.
COS-7 cells were transfected with GFP and its localization was
compared to that of PABP. Immunofluorescence images show no
colocalization of GFP with the marker of stress granules. Bar:
10 mm.
(TIF)
Figure S4 CERKL localizes to stress granules in HeLa
cells under stress conditions. A) Colocalization experiments
of overexpressed CERKL-HA in HeLa cells, untreated (MOCK)
or treated with 500 mM sodium arsenite (SA) for 30 min. In the
presence of SA, CERKL colocalizes with eIF4E, a marker of stress
granules. Images at higher magnification of the rectangles are
shown on the right (ZOOM). All bars: 10 mm. B) CERKL-HA
also colocalizes with another marker of stress granules (PABP) in
HeLa cells, when treated with SA as above or when subjected to a
44uC heat shock for 30 min (two middle panels). This colocaliza-
tion is lost after cycloheximide (CHX) treatment (lower panel).
Images at higher magnification of the rectangles are shown on the
right. All bars: 10 mm. C) CHX does not affect the total amount of
CERKL in the cells. HeLa cells overexpressing CERKL-HA were
incubated at 37uC, 44uC or 44uC plus 100 mg/ml cycloheximide
(+ CHX) and, after 30 min, CERKL levels in cell lysates were
analyzed by Western blot with antibodies that recognize HA
(upper panel) or, as a loading control, tubulin (lower panel). The
numbers below indicate the relative amount of CERKL with
respect to tubulin in each lane.
(TIF)
Figure S5 CERKL interacts with mRNAs. CERKL protein
was purified and serial dilutions of the protein were incubated with
biotinylated mRNAs from COS-7 cells. Specific shifted bands
were observed (arrowheads) at protein concentrations as low as
0.8 mM in COS-7 mRNAs. Bovine serum albumin (first lane,
CONTROL) and His-maltose binding protein (second lane, 0)
were used as negative controls and addition of an excess of non-
biotinylated probes reduced the intensity of the shifted bands (last
lane, COMPETITION).
(TIF)
Figure S6 Isolation of a cytoskeletal fraction. Fraction-
ation of HEK-293T cells to obtain a cytoskeletal fraction (SK) was
carried out as described in Materials and Methods. Purity of each
fraction was analyzed by Western blot using antibodies that
recognize HSP70 and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as markers of the soluble fraction (S), calnexin and porin
as markers of the membrane fraction (M), lamin and histone
H3 as markers of nuclei (N) and chromatin (C), respectively, and
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acetyl-a-tubulin as a microtubule marker. Vimentin (intermediate
filaments marker) was used as a control. H: total homogenate.
(TIF)
Table S1 CERKL interacting proteins.
(DOC)
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